Do Etomidate and Propofol Increase Mortality in the Critically Ill?

June 15, 2023 00:30:21
Do Etomidate and Propofol Increase Mortality in the Critically Ill?
Critical Care Perspectives in Emergency Medicine
Do Etomidate and Propofol Increase Mortality in the Critically Ill?

Jun 15 2023 | 00:30:21

/

Show Notes

Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased harm and mortality.  In this podcast, we discuss the most recent two systematic reviews and meta-analyses that evaluated etomidate and propofol in critically ill patients.  Do we need to change our practice?

Other Episodes

Episode 0

March 25, 2017 00:17:05
Episode Cover

High Dose NTG in ACPE

ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema.  Is it safe? ...

Listen

Episode 0

May 13, 2020 00:21:18
Episode Cover

COVID-19: Toxicities of Potential Therapies

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence....

Listen

Episode 0

November 10, 2022 00:25:12
Episode Cover

What is the Optimal SpO2 Target in Vented Patients?

Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical...

Listen